Pilot Combines Clinician Guided Phenotypes with IMO Health's Unique Terminology Identifiers to Help Clinicians Easily ...
Victoza (active ingredient liraglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist medication manufactured by Novo ...
India’s growing protein gap is fuelling a boom in protein supplements, but are Indians getting enough nutrition from ...
Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, today announces that DBLG2 ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--TheracosBio today announced that Brenzavvy™ (bexagliflozin), an FDA-approved oral sodium-glucose cotransporter 2 (SGLT2) inhibitor, is now available by ...
Stocktwits on MSN
Fortune 50 employer awards Dario contract to deliver AI-powered cardiometabolic care platform
Contract award for over 100,000 eligible employees marks Dario's fifth Fortune 50 client, further reflecting growing demand among large employers for integrated, outcomes-driven chronic condition ...
Ian Wells, former Global Chief Financial Officer of HOYA Vision Care, appointed CFO, bringing multi-billion-dollar P&L leadership and capital-markets disciplineTom West, who led Intersect ENT to its ...
Indian pharma is entering its next growth phase as a new segment gains traction. We analyse four companies building this ...
High humidity causes issues with insulin storage that people with diabetes can often experience. Dr. Sameer Bhardwaj explains ...
('Cosmos Health' or the 'Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has entered into an agreement for the commercialization of its ...
Lately, it has become almost impossible to have a conversation about weight loss without the name semaglutide, more commonly ...
A network meta-analysis of 19 weight-loss drugs concludes that most obesity drugs don’t improve quality of life or cardiovascular health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results